eli lilly glp 1 drugs The Food and Drug Administration has approved the first oral GLP-1 weight loss drug by Lilly, called Foundayo Eli Lilly's Obesity Pill Appears

doi: 10.1016/S0140-6736(08)61206-4

Though GLP-1RAs are increasingly being prescribed for off-label uses, more than nine in 10 of the physicians surveyed across all specialties have prescribed a GLP-1RA medication for weight loss

As with all things in biotech, the future is profoundly uncertain, and progress will always have roadblocks

Eli Lilly, which also makes the weight loss drugs Mounjaro and Zepbound, said it plans to complete seven additional phase 3 clinical trials of retatrutide in 2026, compiling data that will be submitted to the U.S

Cancers (Basel)

Glucagon-like peptide-1 analogues and thyroid cancer: an analysis of cases reported in the european pharmacovigilance database